Symbol="HALO"
AssetType="Common Stock"
Name="Halozyme Therapeutics Inc"
Description="Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company is headquartered in San Diego, California."
CIK="1159036"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="11388 SORRENTO VALLEY ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5749149000"
EBITDA="332883000"
PERatio="32.83"
PEGRatio="-2.5"
BookValue="0.5"
DividendPerShare="0"
DividendYield="0"
EPS="1.33"
RevenuePerShareTTM="5.18"
ProfitMargin="0.258"
OperatingMarginTTM="0.38"
ReturnOnAssetsTTM="0.117"
ReturnOnEquityTTM="1.114"
RevenueTTM="704980000"
GrossProfitTTM="454205000"
DilutedEPSTTM="1.33"
QuarterlyEarningsGrowthYOY="-0.326"
QuarterlyRevenueGrowthYOY="0.383"
AnalystTargetPrice="50.6"
TrailingPE="32.83"
ForwardPE="23.47"
PriceToSalesRatioTTM="13.28"
PriceToBookRatio="81.58"
EVToRevenue="15.76"
EVToEBITDA="31.48"
Beta="1.22"
num_52WeekHigh="59.46"
num_52WeekLow="29.85"
num_50DayMovingAverage="36.32"
num_200DayMovingAverage="43.81"
SharesOutstanding="131680000"
DividendDate="None"
ExDividendDate="None"
symbol="HALO"
open="43.60"
high="44.24"
low="43.16"
price="43.66"
volume="1008192.00"
latest_trading_day="2023-07-28"
previous_close="43.51"
change="0.15"
change_percent="0.3447%"
aroon_positive_momentum_days="15"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="15"
Volume_recent_avg="1432005"
Change_recent_avg="-0.05"
Delta_recent_avg="1.32"
Variance_recent_avg="0.66"
Change_ratio_recent_avg="-0.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="15"
Aroon_momentum_negative="85"
image_negative_thumbnail_id_1="508"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0097.jpeg"
image_negative_thumbnail_id_2="1117"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0150.jpeg"
image_neutral_thumbnail_id_1="548"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="968"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0130.jpeg"
image_positive_thumbnail_id_2="1006"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
